# SIMCAP (NCT03456843)

> Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: newly diagnosed metastatic prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03456843
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Yale University
- Conditions: Stage IV Prostate Adenocarcinoma AJCC v7
- Interventions: Antiandrogen Therapy; Docetaxel; Laboratory Biomarker Analysis; Quality-of-Life Assessment; Questionnaire Administration; Radical Prostatectomy
- Enrollment: 190
- Primary outcome: Failure-free survival (FFS)

## Indexed commentary on SIMCAP so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=simcap-nct03456843